Annovis Bio (ANVS) Announces Positive Phase 2 Efficacy Data for the Treatment of Parkinson's Disease

Go back to Annovis Bio (ANVS) Announces Positive Phase 2 Efficacy Data for the Treatment of Parkinson's Disease
ANV Security Group, Inc. (NYSE: ANVS) Delayed: 12.47 -0.57 (4.37%)
Previous Close $13.04    52 Week High $0.04 
Open $12.54    52 Week Low $0.01 
Day High $12.70    P/E N/A 
Day Low $12.06    EPS $-0.03 
Volume 38,113